Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines

Journal of Infection and Chemotherapy

Volumn 10, Issue 1, 2004, Pages 25-30

  Kobashi, Yoshihiro ^a   Matsushima, Toshiharu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Clinical effect; Combined chemotherapy; Guideline; Pulmonary MAC disease

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CLARITHROMYCIN; ETHAMBUTOL; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; DRUG ERUPTION; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRACTICE GUIDELINE; RADIOLOGY; SPUTUM CULTURE; THROMBOCYTOPENIA; VERTIGO; VISUAL DISORDER;

EID: 1542378121     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0273-3     Document Type: Article

References (21)

1. Sakatani M. Nontuberculous mycobacteriosis (NTM) in Japan -epidemiologic and clinical study. Kekkaku 1994;69:119-24.
2. Primack SL, Logan PM, Hartman TE, Lee KS, Muller NL. Pulmonary tuberculosis and Mycobacterium avium-intracellulare: a comparison of CT findings. Radiology 1995;194:413-7.
3. Ahn CH, Ahn SS, Anderson DT, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1986;134:438-41.
4. Horsburgh CJ Jr, Mason UG, Heifets LB, Southwick K, Labrecque J, Iseman MD. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis 1987;135:418-21.
5. Tsukamura MH, Shimoide H, Kita N, Kondo H, Segawa J, Matsuda N, et al. Clinical picture of lung disease due to Mycobacterium avium-intracellulare complex. Kekkaku 1976;51:41-6.
6. Wallace RJ Jr, Brown BA, Griffith WM, Girard WM, Murphy DT, Onyi GO, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung diseases. Am J Respir Crit Care Med 1994;149:1335-41.
7. Dauzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP, and the Clarithromycin Study Group of France. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 1995;107:1035-40.
8. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156(Suppl):S1-S25.
9. Japanese Society for Tuberculosis. Treatment of nontuberculous mycobacteriosis. Kekkaku 1998;73:599-605.
10. Brown BA, Wallace RJ Jr, Onyi GO. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother 1992;36:1987-90.
11. Wallace RJ Jr, Nash DR, Steele LC, Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol 1986;24:976-81.
12. Suzuki K. Clinical comparison of pulmonary tuberculosis with pulmonary M. avium complex disease. Kekkaku 1995;70:659-63.
13. Tanaka E, Amitani R, Niimi A. Yield of computed tomography and bronchoscopy for diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-6.
14. Suzuki K, Tanaka E, Tsuyuguchi K, Kimoto T, Amitani R. Pathogenesis and clinical features of pulmonary MAC disease. Antibiotics Chemother 1999;15:689-94.
15. Kennedy TP, Weber DJ. Nontuberculous mycobacteria. An underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med 1994;149:1654-8.
16. Swenson SJ, Hartman TE, Williams DE. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 1994;105:49-52.
17. Sakatani M. Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies. Kekkaku 1999;74:377-84.
18. Wallace RJ Jr, Brown BA, Griffith DE. Drug intolerance to high-dose clarithromycin among elderly patients. Diagn Microbiol Infect Dis 1993;16:215-21.
19. Wallace RJ Jr, Brown DE, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med 1996;153:1766-72.
20. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866-72.
21. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.